The David H. Koch Institute for Integrative Cancer Research at MITThe David H. Koch Institute for Integrative Cancer Research at MIT

Massachusetts Institute of Technology

National Cancer Institute Cancer Center

Science + Engineering... Conquering Cancer Together

Bridge Project Workshop on Pediatric Brain Tumors, July 2016

Tyler Jacks, director of the Koch Institute, and David Livingston, deputy director of Dana-Farber/Harvard Cancer Center, provided brief updates and shared tips for the 2016 special off-cycle RFA on pediatric brain cancer (with a preference for pediatric glioma). This event featured presentations by clinicians and researchers actively working in the area of pediatric brain tumor research and/or clinical care. The intention of this workshop was to spur the formation of new research ideas and collaborations between the two institutions (KI/MIT and DF/HCC).

Event videos

Announcement of 2016 Special Off-Cycle RFA
Tyler Jacks, PhD
Director, Koch Institute for Integrative Cancer Research at MIT

David Livingston, MD
Deputy Director, Dana-Farber/Harvard Cancer Center

Clinical overview of pediatric brain tumors
Torunn Yock, M.D. and David Ebb, M.D. 
Massachusetts General Hospital

Pathology, precision medicine and models of pediatric gliomas
Keith Ligon, M.D., Ph.D. 
Dana-Farber Cancer Institute 

Genomic studies of pediatric low-grade gliomas
Rameen Beroukhim, M.D., Ph.D.  
Dana-Farber Cancer Institute 

Current clinical trials and challenges
Karen Wright, M.D. 
Dana-Farber Cancer Institute 

Targeted therapies for pediatric low-grade astrocytomas
Charles Stiles, Ph.D. 
Dana-Farber Cancer Institute 

Delivery of novel combination therapies to gliomas using a targeted liposomal nanoparticle system
Fred Lam, M.D., Ph.D. ​
Koch Institute for Integrative Cancer Research at MIT